# AEON Biopharma, Inc.: Form DEF 14A, filed Jan 23, 2025

- Company: [AEON Biopharma, Inc.](/companies/aeon.md) (CIK 1837607)
- Form: DEF 14A
- Filed: 2025-01-23
- Accepted by EDGAR: Jan 23, 2025, 16:45 ET
- Period: 2025-02-24
- Accession: 0001837607-25-000007
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1837607/000183760725000007/aeon-20250224xdef14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1837607/000183760725000007/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1837607/000183760725000007/aeon-20250224xdef14a.htm

Filed Jan 23, 2025.
Source: SEC EDGAR, the filing index for accession 0001837607-25-000007. Last ingested by Listed: Nov 14, 2026, 22:29 ET. No prices; not investment advice.
